MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Open Forum Infectious Diseases
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,365 results · 1 filter active ·
Results by year
20112025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,365 works in the cohort · of 4,299,418page 11 of 28

Labels cover 2 of 1,365 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,365 of 1,365 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affaboutunlabeled
152. Protective Antibody Levels 7.5 Years After Primary Vaccination in Adolescence With a Recombinant, 4-Component, Meningococcal Serogroup B Vaccine (4CMenB) and Response to a Booster Dose in Adolescents and Young Adults: Phase IIIb Clinical Findings
Terry Nolan, Miguel O’Ryan, Marı́a Elena Santolaya, Ferdinandus de Looze, Helen Marshall, Peter Richmond +9 more
2018· article· en· Open Forum Infectious Diseases· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrowconsensus · none
1
citations
affaboutunlabeled
Influenza Vaccine Effectiveness in the Prevention of Influenza-Related Hospitalization in Canadian Adults Over the 2011/12 Through 2013/14 Season: A Pooled Analysis From the Serious Outcomes Surveillance (SOS) Network of the Canadian Influenza Research Network (CIRN)
Shelly McNeil, Todd F. Hatchette, Melissa K. Andrew, Ardith Ambrose, Guy Boivin, Francisco Díaz‐Mitoma +32 more
2016· article· en· Open Forum Infectious Diseases· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
affaboutunlabeled
LB13. Trivalent Hepatitis B (HepB) Vaccine Yields Superior Seroprotection Rates in Adults: Results from the Phase 3 Double-Blind, Randomized Study Comparing Immunogenicity and Safety of a 3-Dose Regimen of Sci-B-Vac™ and Engerix B® (PROTECT)
Timo Vesikari, Joanne M. Langley, Bruce R. Smith, Pierre Van Damme, Isabel Leroux‐Roels, Geert Leroux‐Roels +6 more
2019· article· en· Open Forum Infectious Diseases· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
1
citations
affgemma · no categorygpt · no categorymodels agree
Toward Relationality in Infectious Disease Research
Elliott M Chemberlin, Kate A. Duchowny, J Probst, Eugene T Richardson, Sonia T. Hegde, Grace A. Noppert
2025· article· en· Open Forum Infectious Diseases· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
1
citations
← previousnext →

How this was built: Screen · Findings · About